Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)-Reference-Cited by-同舟云学术

Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)

Published:2017-04 Issue: Volume:75 Page:190-191
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ieni A.,Angelico G.,Zeppa P.,Tuccari G.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference10 articles.

1. Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: results of GASTric cancer HER2 reassessment study 1 (GASTHER1);Park;Eur J Cancer,2016

2. HER2 status in premalignant, early, and advanced neoplastic lesions of the stomach;Ieni;Dis Markers,2015

3. HER2 heterogeneity in gastric/gastroesophageal cancers: from benchside to practice;Grillo;World J Gastroenterol,2016

4. Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens;Ahn;Oncotarget,2015

5. Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer;Gullo;Endosc Int Open,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies;Journal of Personalized Medicine;2020-02-21